367 related articles for article (PubMed ID: 32234803)
1. Transition to quantitative faecal immunochemical testing from guaiac faecal occult blood testing in a fully rolled-out population-based national bowel screening programme.
Clark G; Strachan JA; Carey FA; Godfrey T; Irvine A; McPherson A; Brand J; Anderson AS; Fraser CG; Steele RJ
Gut; 2021 Jan; 70(1):106-113. PubMed ID: 32234803
[TBL] [Abstract][Full Text] [Related]
2. Switching from guaiac to immunochemical faecal occult blood test increases participation and diagnostic yield of colorectal cancer screening.
Bretagne JF; Piette C; Cosson M; Durand G; Lièvre A
Dig Liver Dis; 2019 Oct; 51(10):1461-1469. PubMed ID: 31151896
[TBL] [Abstract][Full Text] [Related]
3. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.
Denters MJ; Deutekom M; Bossuyt PM; Stroobants AK; Fockens P; Dekker E
Gastroenterology; 2012 Mar; 142(3):497-504. PubMed ID: 22108194
[TBL] [Abstract][Full Text] [Related]
4. Contribution of the OC Sensor
Vitellius C; Laly M; Banaszuk AS; Deherce I; Cornet N; Bertrais S; Saulnier P; Caroli-Bosc FX
Eur J Epidemiol; 2019 Feb; 34(2):163-172. PubMed ID: 30536183
[TBL] [Abstract][Full Text] [Related]
5. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population.
Guittet L; Bouvier V; Mariotte N; Vallee JP; Arsène D; Boutreux S; Tichet J; Launoy G
Gut; 2007 Feb; 56(2):210-4. PubMed ID: 16891354
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England.
Murphy J; Halloran S; Gray A
BMJ Open; 2017 Oct; 7(10):e017186. PubMed ID: 29079605
[TBL] [Abstract][Full Text] [Related]
7. Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals.
Grobbee EJ; Wisse PHA; Schreuders EH; van Roon A; van Dam L; Zauber AG; Lansdorp-Vogelaar I; Bramer W; Berhane S; Deeks JJ; Steyerberg EW; van Leerdam ME; Spaander MC; Kuipers EJ
Cochrane Database Syst Rev; 2022 Jun; 6(6):CD009276. PubMed ID: 35665911
[TBL] [Abstract][Full Text] [Related]
8. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.
Tinmouth J; Lansdorp-Vogelaar I; Allison JE
Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750
[TBL] [Abstract][Full Text] [Related]
9. Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study.
Fraser CG; Matthew CM; Mowat NA; Wilson JA; Carey FA; Steele RJ
Lancet Oncol; 2006 Feb; 7(2):127-31. PubMed ID: 16455476
[TBL] [Abstract][Full Text] [Related]
10. Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms.
Dancourt V; Lejeune C; Lepage C; Gailliard MC; Meny B; Faivre J
Eur J Cancer; 2008 Oct; 44(15):2254-8. PubMed ID: 18760592
[TBL] [Abstract][Full Text] [Related]
11. Faecal immunochemical tests versus colonoscopy for post-polypectomy surveillance: an accuracy, acceptability and economic study.
Atkin W; Cross AJ; Kralj-Hans I; MacRae E; Piggott C; Pearson S; Wooldrage K; Brown J; Lucas F; Prendergast A; Marchevsky N; Patel B; Pack K; Howe R; Skrobanski H; Kerrison R; Swart N; Snowball J; Duffy SW; Morris S; von Wagner C; Halloran S
Health Technol Assess; 2019 Jan; 23(1):1-84. PubMed ID: 30618357
[TBL] [Abstract][Full Text] [Related]
12. High test positivity and low positive predictive value for colorectal cancer of continued faecal occult blood test screening after negative colonoscopy.
Brown JP; Wooldrage K; Wright S; Nickerson C; Cross AJ; Atkin WS
J Med Screen; 2018 Jun; 25(2):70-75. PubMed ID: 28467146
[TBL] [Abstract][Full Text] [Related]
13. Increased uptake and improved outcomes of bowel cancer screening with a faecal immunochemical test: results from a pilot study within the national screening programme in England.
Moss S; Mathews C; Day TJ; Smith S; Seaman HE; Snowball J; Halloran SP
Gut; 2017 Sep; 66(9):1631-1644. PubMed ID: 27267903
[TBL] [Abstract][Full Text] [Related]
14. Guaiac versus immunochemical tests: faecal occult blood test screening for colorectal cancer in a rural community.
Hughes K; Leggett B; Del Mar C; Croese J; Fairley S; Masson J; Aitken J; Clavarino A; Janda M; Stanton WR; Tong S; Newman B
Aust N Z J Public Health; 2005 Aug; 29(4):358-64. PubMed ID: 16222934
[TBL] [Abstract][Full Text] [Related]
15. Basic variables at different positivity thresholds of a quantitative immunochemical test for faecal occult blood.
Castiglione G; Grazzini G; Miccinesi G; Rubeca T; Sani C; Turco P; Zappa M
J Med Screen; 2002; 9(3):99-103. PubMed ID: 12370319
[TBL] [Abstract][Full Text] [Related]
16. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
[TBL] [Abstract][Full Text] [Related]
17. Interval cancers in a national colorectal screening programme based on faecal immunochemical testing: Implications for faecal haemoglobin concentration threshold and sex inequality.
Clark GR; Godfrey T; Purdie C; Strachan J; Carey FA; Fraser CG; Steele RJ
J Med Screen; 2024 Mar; 31(1):21-27. PubMed ID: 37469171
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the performance of guaiac-based and two immunochemical fecal occult blood tests for identifying advanced colorectal neoplasia in Taiwan.
Ou CH; Kuo FC; Hsu WH; Lu CY; Yu FJ; Kuo CH; Wang JY; Wu MT; Shiea J; Wu DC; Hu HM
J Dig Dis; 2013 Sep; 14(9):474-83. PubMed ID: 23701988
[TBL] [Abstract][Full Text] [Related]
19. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
Smith A; Young GP; Cole SR; Bampton P
Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938
[TBL] [Abstract][Full Text] [Related]
20. Interval cancers using a quantitative faecal immunochemical test (FIT) for haemoglobin when colonoscopy capacity is limited.
Digby J; Fraser CG; Carey FA; Lang J; Stanners G; Steele RJ
J Med Screen; 2016 Sep; 23(3):130-4. PubMed ID: 26589788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
